HomeNNNN • NASDAQ
Anbio Biotechnology
add
$7.75
0.64%
Pre-market:(0.00%)0.00
$7.75
Closed: May 23, 6:09:49 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.17M | -36.06% |
Operating expense | 1.79M | 249.33% |
Net income | -611.90K | -266.94% |
Net profit margin | -52.40 | -361.09% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.76M | 21.40% |
Total assets | 18.92M | 19.67% |
Total liabilities | 1.73M | 74.23% |
Total equity | 17.19M | — |
Shares outstanding | 43.89M | — |
Price to book | 19.02 | — |
Return on assets | -10.59% | — |
Return on capital | -11.66% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -611.90K | -266.94% |
Cash from operations | 740.65K | 220.12% |
Cash from investing | 99.47K | 35.30% |
Cash from financing | -114.88K | -207.88% |
Net change in cash | 725.24K | 266.11% |
Free cash flow | -500.94K | -394.17% |
Previous close
$7.80
Day range
$7.62 - $8.22
Year range
$5.18 - $8.22
Market cap
340.16M USD
Avg Volume
42.73K
P/E ratio
464.63
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2021
Website
Employees
27
